Current aspects of modes of action of dapsone.
Wozel
G
G
Department of Dermatology, Medical Academy Carl Gustav Carus, Dresden, German Democratic Republic.
Barth
J
J
D001798:Blood Proteins / Q000378:metabolism; D002633:Chemotaxis / Q000187:drug effects; D003165:Complement System Proteins / Q000276:immunology; D003622:Dapsone / Q000276:immunology / Q000494:pharmacology*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008247:Lysosomes / Q000201:enzymology; D009504:Neutrophils / Q000187:drug effects / Q000503:physiopathology; D010743:Phospholipids / Q000378:metabolism; D010960:Plasminogen Activators / Q000032:analysis; D011506:Proteins / Q000378:metabolism; D015843:Serpins; D000515:alpha 1-Antitrypsin
D001798:Blood Proteins; D010743:Phospholipids; D011506:Proteins; D015843:Serpins; D000515:alpha 1-Antitrypsin; D003622:Dapsone; D003165:Complement System Proteins; D010960:Plasminogen Activators